The ISUOG World Congress 2024 is the must-see event for ultrasound professionals in obstetrics and gynecology. The 4-day, multiple-stream program will give you the opportunity to hear from the field's leading experts in person.

Take a look at the program overview to see what's in store for the 2024 Congress:

Scientific program session types:

The scientific program will include a mixture of sessions to give you the full picture of ultrasound in 2024.
  • Masterclass sessions – these exciting sessions will be led by an expert in their field and explore topics in depth giving you the latest updates and thinking from those at the frontline of research.
  • Workshops – these interactive sessions will offer you a mix of debates, lectures, discussions and scans and images from leading ultrasound experts.
  • Oral communication and oral presentation sessions – these fast-paced sessions showcase the highest quality abstracts from the event. You will hear directly from the authors themselves and have the chance to question them on their work.
  • Ultrasound demonstrations – watch live ultrasound scan demonstrations conducted by ISUOG’s world leading experts as they talk you through how they perform an ultrasound scan and interpret the live images.
  • Plenary lectures - hear one-off talks from leading speakers from the OBGYN profession and outside, to really make you think!

Confirmed plenary speakers

David Rhew is Microsoft’s Global Chief Medical Officer & VP of Healthcare. He has served as Microsoft’s International Coordinator for the Pandemic Response, where he worked with WHO to develop their World Health Data Hub, CDC to standup their vaccine data lake, and U.S. states to roll-out COVID-19 vaccines. 

He is Adjunct Professor at Stanford University; holds six U.S. technology patents that enable authoring, mapping, and integration of clinical decision support into electronic health records; and has been recognized as one of the 50 most influential clinician executives by Modern Healthcare.

Dr. Rhew received his Bachelors of Science degrees in computer science and cellular molecular biology from University of Michigan. He received his MD degree from Northwestern University and completed internal medicine residency at Cedars-Sinai Medical Center. He completed fellowships in health services research at Cedars-Sinai and infectious diseases at UCLA.

He has served as CMO and VP for Samsung; and SVP and CMO at Zynx Health. David has served on National Quality Forum’s Executive CSAC Board and chaired the Consumer Technology Association’s Health Technology Board. He currently sits on AdvaMed’s Digital Health Board and the Governing Committee for NESTcc, the medical device advisory group for FDA, CMS, and NIH.
Read more

Dr Özge Tunçalp is a physician and public health researcher with more than 15 years of experience, currently based in Geneva at Department of Sexual and Reproductive Health and Research/HRP special programme, WHO. Using mixed and innovative methodologies, she leads the research and guideline portfolios for antenatal care, which included first WHO recommendation on obstetric ultrasound, and quality of care including respectful maternal and newborn care. She is an honorary professor at London School of Hygiene and Tropical Medicine.

Read more

Professor Huirne is a Gynaecologist and senior researcher at the Amsterdam University Medical Center (VUmc), Amsterdam, the Netherlands. She leads the Uterine Repair Center (URC) at the VUmc. This center serves women suffering non-cancerous gynaecological disorders, such as myomas, adenomyosis, niches or congenital uterine abnormalities.
She specialises in minimally invasive treatments of uterine abnormalities. She has been involved in the development of various new diagnostic techniques and treatments for uterine abnormalities, and founded the European expert group on uterine abnormalities.
Read more

Francesc Figueras 

•    Head of Fetal-Maternal Medicine at Hospital Clinic (Barcelona) and Full Professor of the University of Barcelona.  
•    Research interest in Fetal Growth Restriction and Preeclampsia: ~285 authored articles in indexed journals (~700 Impact Factor). H-index 57. 
•    Principal Investigator of 9 public-funded competitive research projects. 
•    Master Degree in Health Methodology by the University Autonomous of Barcelona.
•    Postgraduate Degree in Public Health by the University of Edinburgh.  

Read more

More plenary speakers to be announced shortly...


At the 2024 Congress, you can expect to see sessions and lectures on the following topics.
  • Screening for pregnancy complications (stillbirth, preterm birth, pre-eclampsia)
  • Screening of chromosomal anomalies (incl. cfDNA, genomics and gene therapy)
  • Fetal brain and CNS anomalies
  • Fetal heart, CHD and cardiac functions
  • Fetal disease and structural abnormalities
  • Fetal growth: normal and abnormal
  • Multiple pregnancy
  • Placenta anomalies including spectrum of placenta accreta disorders
  • Ultrasound in the labour ward
  • Fetal interventions
  • Artificial intelligence, education, simulation, safety and other innovations
  • Fetal and maternal infections including coronavirus
  • Maternal Medicine (maternal diseases that can affect pregnancy outcomes)
  • Early pregnancy
  • Managing ovarian masses
  • Pelvic pain and endometriosis
  • Ultrasound and fertility
  • Bleeding, endometrial and myometrial pathology
  • Imaging in oncology
  • Urogynecology and ultrasound guided procedures